| ISIN | LU0188501687 |
|---|---|
| Valor Number | 1812196 |
| Bloomberg Global ID | BBG000Q3KYW2 |
| Fund Name | Pictet - Longevity -Z USD |
| Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
| Fund Provider | Pictet Asset Management S.A. |
| Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
| Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
| Asset Class | Equities |
| EFC Category | Equity Health Care |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
| Investment Strategy *** | The investment objective of the fund is to increase the value of your investment while seeking to achieve a positive social impact. The Fund aims to achieve long-term capital growth by investing in companies that support and enhance longevity, as it pertains to individuals and society. |
| Peculiarities |
| Current Price * | 490.60 USD | 04.12.2025 |
|---|---|---|
| Previous Price * | 489.17 USD | 03.12.2025 |
| 52 Week High * | 532.96 USD | 07.02.2025 |
| 52 Week Low * | 433.35 USD | 07.04.2025 |
| NAV * | 490.60 USD | 04.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 521,630,278 | |
| Unit/Share Assets *** | 37,703 | |
| Trading Information SIX | ||
| YTD Performance | -1.12% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | -12.90% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
| 1 month | +3.03% |
04.11.2025 - 04.12.2025
04.11.2025 04.12.2025 |
| 3 months | +2.33% |
04.09.2025 - 04.12.2025
04.09.2025 04.12.2025 |
| 6 months | -0.35% |
04.06.2025 - 04.12.2025
04.06.2025 04.12.2025 |
| 1 year | -4.88% |
04.12.2024 - 04.12.2025
04.12.2024 04.12.2025 |
| 2 years | +10.59% |
04.12.2023 - 04.12.2025
04.12.2023 04.12.2025 |
| 3 years | +14.24% |
05.12.2022 - 04.12.2025
05.12.2022 04.12.2025 |
| 5 years | +12.74% |
04.12.2020 - 04.12.2025
04.12.2020 04.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 3.4125 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 04.12.2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Boston Scientific Corp | 7.20% | |
|---|---|---|
| Intuitive Surgical Inc | 5.53% | |
| Lonza Group Ltd | 5.46% | |
| Danaher Corp | 5.34% | |
| AstraZeneca PLC | 4.94% | |
| Eli Lilly and Co | 4.74% | |
| Agilent Technologies Inc | 4.45% | |
| Garmin Ltd | 4.09% | |
| Steris PLC | 3.93% | |
| Haleon PLC | 3.68% | |
| Last data update | 31.10.2025 | |
| TER *** | 0.13% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.00% |
| Ongoing Charges *** | 0.11% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |